Europe

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The firm focuses on investing in businesses that enable better care at lower cost, with a strong presence in Europe and North America. Gilde Healthcare is headquartered in Utrecht, the Netherlands, with additional offices in Frankfurt, Germany, and Boston, USA.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. With a transatlantic presence, SR One focuses on companies with strong fundamentals and novel approaches to addressing diseases, aiming to reimagine today's science for tomorrow's medicines.

VTC Ventures is a venture capital firm that invests in early-stage life sciences and high-growth technology companies. It operates through two main investment vehicles: the VTC Innovation Fund, focusing on Series A and B rounds, and the VTC Seed Fund, targeting seed stage investments. Primarily funded by Virginia Tech and Carilion Clinic, VTC Ventures aims to create long-term value within the Virginia Tech and Carilion Clinic ecosystem, while also pursuing high-growth opportunities across Virginia, the Mid-Atlantic, and nationwide.

Rosetta Capital is a UK-based venture capital firm specializing in the life sciences and medical device sectors. With a global investment approach, the firm focuses on building leading healthcare companies and breakthrough technologies that enhance human lives. Rosetta Capital primarily invests through direct secondary transactions, providing flexible liquidity solutions to investors and corporations. Over its 20+ year history, the firm has made over 50 venture investments, demonstrating extensive expertise in executing complex transactions efficiently.

General Inception is a Deep Tech Venture studio that partners with extraordinary technical co-founders to solve fundamental problems in science-based company creation. They focus on bringing together the right people, customers, and funding to start and scale successful companies. Their model involves guiding companies from idea to seed investment and beyond, providing legal, financial, business strategy, and operational support. General Inception works across various industry categories, including Engineered Biology, Life Science Tools & Diagnostics, and Therapeutics, creating an interconnected ecosystem to access new technologies, customers, and markets.

Tech Council Ventures is a venture capital firm that invests in early-stage, rapid-growth technology companies in the Mid-Atlantic region. The firm focuses on sectors such as life sciences, digital health, biotech, medical devices, and therapeutics. With a strong network and expertise, Tech Council Ventures aims to support entrepreneurs by providing capital, strategic guidance, and access to a wide range of resources to help them succeed in large and growing markets.

Western Technology Investment (WTI) is a pioneering venture debt firm that has been providing capital to startups since 1980. With a focus on minimizing dilution, WTI has supported over 1,400 companies across major innovation sectors. The firm is known for its flexible, scalable, and partner-driven approach, offering debt capital from the seed stage through to public listing. WTI is currently investing from its 11th institutional fund, backed by institutional LPs including endowments, non-profits, academic institutions, and select family offices.

UTEC, founded in 2004, is a venture capital firm that collaborates with universities and research institutions globally, focusing on science and technology to create new industries that address global and human challenges. With a strong emphasis on seed and early-stage investments, UTEC has managed five funds totaling approximately 850 billion yen, investing in over 150 startups, with 20 achieving IPOs and 20 undergoing M&A. UTEC's mission is to leverage capital, talent, and knowledge to solve world and human issues through innovative startups.

Bay City Capital is a leading venture capital firm established in 1997, focusing on early-stage to growth equity investments in the life sciences sector. With a mission to drive innovation in healthcare, the firm has managed eight venture capital funds with over $1.6 billion in capital commitments and has invested in more than 100 companies globally. Bay City Capital is dedicated to advancing transformative biopharmaceutical investments across various geographies, including the United States, Canada, Western Europe, and China.

Novo Holdings is a leading holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. The company is the controlling shareholder of Novo Nordisk and Novonesis and manages a diverse investment portfolio with a long-term return perspective. Novo Holdings invests in life science companies at all stages of development and manages a broad portfolio of equities, bonds, real estate, infrastructure assets, and private equity investments. The firm is committed to improving people’s health and the sustainability of society and the planet by generating attractive long-term returns.

Keiretsu Forum is a global investment community of accredited private equity angel investors, venture capitalists, and corporate/institutional investors. Founded in 2000 by Randy Williams in the San Francisco East Bay, it has grown into a worldwide network with 53 chapters across 4 continents. The forum is renowned for its high-quality, diverse investment opportunities and is ranked as one of the most active venture investors in the USA. Keiretsu Forum emphasizes a holistic approach to investment, fostering interlocking relationships with partners and key resources to offer top-tier deal flow and investment opportunities. The community is also actively involved in social and charitable activities, enhancing its global network of capital, resources, and deal flow.